Protagonist Therapeutics, Inc.
Developing peptide therapeutics across hematology and immune-mediated disease, including rusfertide and icotrokinra.
Immunology & hematology · Peptide therapeutics · Commercial partner + late clinical
Developing peptide therapeutics across hematology and immune-mediated disease, including rusfertide and icotrokinra.
Immunology & hematology · Peptide therapeutics · Commercial partner + late clinical